Diagnos (TSE:ADK)
:ADK
Want to see TSE:ADK full AI Analyst Report?
ADK Stock Chart & Stats
C$0.36
C$0.03(9.38%)
At close: 4:00 PM EST
C$0.36
C$0.03(9.38%)
Day’s Range― - ―
52-Week RangeC$0.18 - C$0.42
Previous CloseN/A
Volume270.50K
Average Volume (3M)342.67K
Market Cap
C$28.90M
Enterprise ValueC$25.54M
Total Cash (Recent Filing)C$3.40M
Total Debt (Recent Filing)C$2.00M
Price to Earnings (P/E)―
Beta0.49
Next Earnings
Jun 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding120,412,550
10 Day Avg. Volume531,548
30 Day Avg. Volume342,665
Financial Highlights & Ratios
PEG Ratio-0.45
Price to Book (P/B)-6.56
Price to Sales (P/S)117.69
P/FCF Ratio-9.28
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improving Equity PositionTTM and recent annual positive equity indicates the balance sheet has begun to recover, which reduces acute insolvency risk and gives management more optionality for refinancing or strategic choices. A repaired equity base is a durable precursor to restoring investor confidence if losses abate.
Lean Operating FootprintA very small headcount implies a lean cost structure and operational flexibility, helping preserve runway while the company pursues product-market fit. Over months, low fixed overhead can reduce cash burn sensitivity and enable faster pivots or targeted hiring tied to revenue inflection.
Healthcare IT Industry ExposureOperating in healthcare information services aligns the company with secular trends—digitization, data-driven care, and regulatory reporting—that support sustained market demand. Structural tailwinds can underpin long-term revenue opportunities if the firm can execute product and sales strategies.
Bears Say
Declining Revenue And Deep LossesA multi-period revenue decline combined with negative gross and operating margins signals weak product-market traction and limited pricing power. Persistent losses constrain reinvestment in R&D and sales, making it harder to scale and requiring external financing to sustain operations over several months.
Persistent Cash BurnConsistent negative OCF and FCF indicate ongoing cash consumption with no evidence of conversion improvement. This elevates refinancing and dilution risk, limits ability to fund growth organically, and means the company remains dependent on external capital unless cash generation turns positive.
High Leverage Relative To EquityMaterial debt versus a small and volatile equity base reduces financial flexibility and raises default or covenant risk if losses continue. Erratic equity swings make leverage metrics unstable, complicating refinancing and increasing the cost of capital for strategic investments over the coming months.
Diagnos News
ADK FAQ
What was Diagnos’s price range in the past 12 months?
Diagnos lowest stock price was C$0.18 and its highest was C$0.41 in the past 12 months.
What is Diagnos’s market cap?
Diagnos’s market cap is C$28.90M.
When is Diagnos’s upcoming earnings report date?
Diagnos’s upcoming earnings report date is Jun 04, 2026 which is in 37 days.
How were Diagnos’s earnings last quarter?
Diagnos released its earnings results on Feb 25, 2026. The company reported -C$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.01.
Is Diagnos overvalued?
According to Wall Street analysts Diagnos’s price is currently Overvalued.
Does Diagnos pay dividends?
Diagnos does not currently pay dividends.
What is Diagnos’s EPS estimate?
Diagnos’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Diagnos have?
Diagnos has 120,412,550 shares outstanding.
What happened to Diagnos’s price movement after its last earnings report?
Diagnos reported an EPS of -C$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.754%.
Which hedge fund is a major shareholder of Diagnos?
Currently, no hedge funds are holding shares in TSE:ADK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Diagnos
DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. The company was founded in 1998 and is headquartered in Brossard, Canada.
Technical Analysis
Rocket Doctor AI
―
Comprehensive Healthcare Systems Inc
―
UniDoc Health Corp
―
PanGenomic Health, Inc. Class A
―
DiagnaMed Holdings Corp.
―
Options Prices
Currently, No data available
---